| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Protara Therapeutics, Inc. | Chief Medical Officer | Common Stock | 78,181 | $416,704 | $5.33 | 16 Jan 2026 | Direct |
| Protara Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 158,000 | 16 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TARA | Protara Therapeutics, Inc. | 16 Jan 2026 | 2 | $0 | 4 | Chief Medical Officer | 21 Jan 2026, 16:36 |
| TARA | Protara Therapeutics, Inc. | 15 Apr 2025 | 2 | $0 | 4 | Chief Medical Officer | 17 Apr 2025, 16:10 |
| TARA | Protara Therapeutics, Inc. | 15 Apr 2025 | 0 | $0 | 3 | Chief Medical Officer | 17 Apr 2025, 16:05 |